UK markets closed

Biocartis Group NV (BCARTB.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
0.60850.0000 (0.00%)
At close: 03:30PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
60,612
57,481
48,269
43,128
37,444
Cost of revenue
29,457
29,799
33,922
26,284
21,328
Gross profit
31,155
27,682
14,347
16,844
16,116
Operating expenses
Research development
37,506
38,393
48,054
40,927
39,844
Selling general and administrative
8,922
8,573
6,403
6,541
9,813
Total operating expenses
73,921
74,433
76,645
63,226
71,461
Operating income or loss
-42,766
-46,751
-62,298
-46,382
-55,345
Interest expense
16,091
11,187
9,320
10,184
7,099
Income before tax
-68,035
-65,621
-71,715
-63,162
-64,167
Income tax expense
-167
-240
-243
-228
-99
Income from continuing operations
-67,868
-65,381
-71,472
-62,934
-64,068
Net income
-67,868
-65,381
-71,472
-62,934
-64,068
Net income available to common shareholders
-67,868
-65,381
-71,472
-62,934
-64,068
Basic EPS
-0.92
-1.08
-1.24
-0.95
-0.97
Diluted EPS
-0.92
-1.08
-1.24
-0.95
-0.97
Basic average shares
78,389
60,546
57,546
66,381
65,752
Diluted average shares
78,389
60,546
57,546
66,381
65,752